Recent 8-K filings for CLOQ
Highest-materiality recent filing
Cyberloq shareholders approve increase in authorized shares from 200M to 300M
- Shareholders approved amendment by written consent on July 31, 2024.
- Authorized common stock increased from 200,000,000 to 300,000,000 shares.
-
CyberloQ inks 12-month licensing pact with Relevate AI; $750/mo fee plus 10% commissions
Monthly license fee of $750; CyberloQ receives $5 commission per user for sales it originates for Relevate.
-
Cyberloq creates Series B Preferred Stock convertible 1:1,000 upon company sale
Authorized 50,000 shares of Series B Preferred Stock at $0.001 par value.
-
CyberloQ earns SOC 2 Type I certification, files second Medicare/Medicaid fraud prevention patent
Earned SOC 2 Type I certification from AICPA on April 23, 2025, covering security, availability, processing integrity, confidentiality, and privacy.
-
Non-exclusive referral agreement with TransactPay for EU, UK, Australia; 10% commission on sales.
-
Cyberloq shareholders approve increase in authorized shares from 200M to 300M
Shareholders approved amendment by written consent on July 31, 2024.
Materiality & sentiment trend
Max materiality 0.55 · Median 0.50 · Most common event other_material